Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The impact of rheumatoid arthritis and biologics on employers and payers.

Literature DB >> 22478712

The impact of rheumatoid arthritis and biologics on employers and payers.

Abstract

Paresh Chaudhari, PharmD, MPH, frames the business case for employers to look beyond the direct medical costs of treatment of RA and consider employee health benefits as an investment.

Entities: Disease

Year: 2008 PMID： 22478712 PMCID： PMC2706169

Source DB: PubMed Journal: Biotechnol Healthc ISSN： 1554-169X

45 in total

1. Guidelines for the management of rheumatoid arthritis: 2002 Update.

Authors:
Journal: Arthritis Rheum Date: 2002-02

Review 2. A review of health-related workplace productivity loss instruments.

Authors: Jennifer H Lofland; Laura Pizzi; Kevin D Frick
Journal: Pharmacoeconomics Date: 2004 Impact factor: 4.981

Review 3. Biosimilar drugs : concerns and opportunities.

Authors: Armando A Genazzani; Giovanni Biggio; Achille Patrizio Caputi; Mario Del Tacca; Filippo Drago; Roberto Fantozzi; Pier Luigi Canonico
Journal: BioDrugs Date: 2007 Impact factor: 5.807

4. Work disability in rheumatoid arthritis 10 years after the diagnosis.

Authors: T Sokka; H Kautiainen; T Möttönen; P Hannonen
Journal: J Rheumatol Date: 1999-08 Impact factor: 4.666

Review 5. The costs of rheumatoid arthritis: an international long-term view.

Authors: K M Pugner; D I Scott; J W Holmes; K Hieke
Journal: Semin Arthritis Rheum Date: 2000-04 Impact factor: 5.532

6. The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment.

Authors: Ferdinand C Breedveld; Michael H Weisman; Arthur F Kavanaugh; Stanley B Cohen; Karel Pavelka; Ronald van Vollenhoven; John Sharp; John L Perez; George T Spencer-Green
Journal: Arthritis Rheum Date: 2006-01

7. Employers' use of value-based purchasing strategies.

Authors: Meredith B Rosenthal; Bruce E Landon; Sharon-Lise T Normand; Richard G Frank; Thaniyyah S Ahmad; Arnold M Epstein
Journal: JAMA Date: 2007-11-21 Impact factor: 56.272

8. Association between etanercept use and employment outcomes among patients with rheumatoid arthritis.

Authors: Edward Yelin; Laura Trupin; Patricia Katz; Deborah Lubeck; Stephanie Rush; Lee Wanke
Journal: Arthritis Rheum Date: 2003-11

9. The costs of early inflammatory joint disease: a population-based study in southern Sweden.

Authors: M K Söderlin; H Kautiainen; D Jonsson; T Skogh; M Leirisalo-Repo
Journal: Scand J Rheumatol Date: 2003 Impact factor: 3.641

10. Anakinra as a new therapeutic option in rheumatoid arthritis: clinical results and perspectives.

Authors: B Bresnihan
Journal: Clin Exp Rheumatol Date: 2002 Sep-Oct Impact factor: 4.473

4 in total

Review 1. Methotrexate revisited: considerations for subcutaneous administration in RA.

Authors: Randy Jay
Journal: Clin Rheumatol Date: 2014-11-30 Impact factor: 2.980

2. State of Knowledge on Molecular Adaptations to Exercise in Humans: Historical Perspectives and Future Directions.

Authors: Kaleen M Lavin; Paul M Coen; Liliana C Baptista; Margaret B Bell; Devin Drummer; Sara A Harper; Manoel E Lixandrão; Jeremy S McAdam; Samia M O'Bryan; Sofhia Ramos; Lisa M Roberts; Rick B Vega; Bret H Goodpaster; Marcas M Bamman; Thomas W Buford
Journal: Compr Physiol Date: 2022-03-09 Impact factor: 8.915

3. An Exercise and Educational and Self-management Program Delivered With a Smartphone App (CareHand) in Adults With Rheumatoid Arthritis of the Hands: Randomized Controlled Trial.

Authors: Pablo Rodríguez Sánchez-Laulhé; Luis Gabriel Luque-Romero; Francisco José Barrero-García; Ángela Biscarri-Carbonero; Jesús Blanquero; Alejandro Suero-Pineda; Alberto Marcos Heredia-Rizo
Journal: JMIR Mhealth Uhealth Date: 2022-04-07 Impact factor: 4.947

4. A mobile app using therapeutic exercise and education for self-management in patients with hand rheumatoid arthritis: a randomized controlled trial protocol.

Authors: Pablo Rodríguez-Sánchez-Laulhé; Luis Gabriel Luque-Romero; Jesús Blanquero; Alejandro Suero-Pineda; Ángela Biscarri-Carbonero; Francisco José Barrero-García; Alberto Marcos Heredia-Rizo
Journal: Trials Date: 2020-09-10 Impact factor: 2.279

4 in total